Search

Glenn Fu Phones & Addresses

  • Dublin, CA
  • Alameda, CA

Work

Company: Cellular research Dec 2011 to Jul 2016 Position: Scientist and co-founder

Education

Degree: Doctorates, Doctor of Philosophy School / High School: University of Michigan 1991 to 1996 Specialities: Philosophy

Languages

English

Industries

Biotechnology

Resumes

Resumes

Glenn Fu Photo 1

Glenn Fu

View page
Location:
2771 east Cog Hill Ter, Dublin, CA 94568
Industry:
Biotechnology
Work:
Cellular Research Dec 2011 - Jul 2016
Scientist and Co-Founder

Affymetrix 2006 - Dec 2011
Director, Genotyping Research

Perlegen Sciences 2004 - 2006
Director

Incyte Nov 1998 - Apr 2004
Director of Molecular Biology

Hyseq Jun 1997 - Nov 1998
Scientist
Education:
University of Michigan 1991 - 1996
Doctorates, Doctor of Philosophy, Philosophy
University of California, Berkeley 1989 - 1991
Bachelors, Bachelor of Arts, Biology
Languages:
English

Publications

Us Patents

Construction Of Uni-Directionally Cloned Cdna Libraries From Messenger Rna For Improved 3€² End Dna Sequencing

View page
US Patent:
6387624, May 14, 2002
Filed:
Apr 14, 2000
Appl. No.:
09/549770
Inventors:
Glenn K. Fu - El Cerrito CA
Steven Starnes - East Palo Alto CA
Laura L. Stuve - Los Gatos CA
Assignee:
Incyte Pharmaceuticals, Inc. - Palo Alto CA
International Classification:
C12Q 168
US Classification:
435 6, 435 911, 536 231, 536 243, 935 16, 935 77, 935 78
Abstract:
Methods are provide for preparing cDNA corresponding to a mRNA. In the subject methods, a mRNA is first contacted with a mixture of primers under first strand cDNA synthesis conditions. The primer mixture contains primers that have at least 10 contiguous deoxythymidines, a double stranded restriction enzyme recognition sequence near one end and a non-polyA-complementary region near the other end, where the non-polyA-complementary region is -VV, -VTV, -VTTV, -VTTTV, and -VVVVV. The resultant cDNA is modified such that the polyT tail is substantially removed. The modified cDNA is then ligated into a vector. The subject methods find use in a variety of applications, and find particular use in the sequencing of DNA and in the synthesis of cDNA libraries.

Cdna Libraries And Methods For Their Production

View page
US Patent:
6509175, Jan 21, 2003
Filed:
Apr 11, 2001
Appl. No.:
09/833498
Inventors:
Glenn K. Fu - Dublin CA
Laura L. Stuve - Los Gatos CA
Walter H. Lee - Campbell CA
Irene Ni - San Leandro CA
Assignee:
Incyte Genomics, Inc. - Palo Alto CA
International Classification:
C12P 1934
US Classification:
435 9151, 435 6, 435 911, 435 912, 436 94, 536 231, 536 243, 536 2433
Abstract:
The present invention provides new methods of synthesizing cDNAs, methods of verifying full-length cDNAs, methods of producing cDNA libraries enriched for full-length inserts, and the like.

Construction Of Uni-Directionally Cloned Cdna Libraries From Messenger Rna For Improved 3′ End Dna Sequencing

View page
US Patent:
6864057, Mar 8, 2005
Filed:
Jan 4, 2002
Appl. No.:
10/039890
Inventors:
Glenn K. Fu - El Cerrito CA, US
Steven Starnes - East Palo Alto CA, US
Laura L. Stuve - Los Gatos CA, US
Assignee:
Incyte Corporation - Palo Alto CA
International Classification:
C12Q001/68
C12P019/34
C07H021/02
C07H021/04
US Classification:
435 6, 435 9151, 536 231, 536 243
Abstract:
Methods are provide for preparing cDNA corresponding to a mRNA. In the subject methods, a mRNA is first contacted with a mixture of primers under first strand cDNA synthesis conditions. The primer mixture contains primers that have at least 10 contiguous deoxythymidines, a double stranded restriction enzyme recognition sequence near one end and a non-polyA-complementary region near the other end, where the non-polyA-complementary region is -VV, -VTV, -VTTV, -VTTTV, and -VVVVV. The resultant cDNA is modified such that the polyT tail is substantially removed. The modified cDNA is then ligated into a vector. The subject methods find use in a variety of applications, and find particular use in the sequencing of DNA and in the synthesis of cDNA libraries.

Method For Identification Of Cdnas Encoding Signal Peptides

View page
US Patent:
20020127557, Sep 12, 2002
Filed:
Mar 9, 2001
Appl. No.:
09/803317
Inventors:
Ruoying Tan - Foster City CA, US
Glenn Fu - Dublin CA, US
Michael Rose - Mountain View CA, US
Juan Zhang - Cupertino CA, US
International Classification:
C12Q001/68
G01N033/53
C12Q001/02
C12N015/00
US Classification:
435/006000, 435/007100, 435/320100, 435/029000
Abstract:
The present invention provides a method in which cDNAs that encode signal sequences for secreted or membrane-associated proteins are isolated using a fusion protein that directs secretion of a molecule that provides antibiotic resistance, e.g., -lactamase. The present method allows the isolation of signal peptide-associated proteins that may be difficult to isolate with other techniques. Moreover, the present method is amenable to throughput screening techniques and automation, and especially in validating the presence of the signal sequence via expression of the protein in both prokaryotic and eukaryotic cells. This invention provides a powerful and approach to the large scale isolation of novel secreted proteins.

Cdna Libraries And Methods For Their Production

View page
US Patent:
20030104468, Jun 5, 2003
Filed:
Jan 21, 2003
Appl. No.:
10/349043
Inventors:
Glenn Fu - Dublin CA, US
Laura Stuve - Los Gatos CA, US
Walter Lee - Campbell CA, US
Irene Ni - San Leandro CA, US
International Classification:
C12Q001/68
C12P019/34
US Classification:
435/006000, 435/091200
Abstract:
The present invention provides new methods of synthesizing cDNAs, methods of verifying full-length cDNAs, methods of producing cDNA libraries enriched for full-length inserts, and the like.

G-Protein Coupled Receptors

View page
US Patent:
20040152157, Aug 5, 2004
Filed:
Oct 27, 2003
Appl. No.:
10/476204
Inventors:
Michael Thornton - Oakland CA, US
Narinder Chawla - Union City CA, US
Kimberly Gietzen - San Jose CA, US
Anita Swarnakar - San Francisco CA, US
Mariah Baughn - Los Angeles CA, US
Bridget Warren - San Marcos CA, US
Jayalaxmi Ramkumar - Fremont CA, US
Monique Yao - Mountain View CA, US
Pei Jin - Palo Alto CA, US
Deborah Kallick - Galveston TX, US
Thomas Richardson - Redwood City CA, US
Mark Borowsky - Needham MA, US
Richard Graul - San Francisco CA, US
Junming Yang - San Jose CA, US
Li Ding - Creve Coeur MO, US
Glenn Fu - Dublin CA, US
International Classification:
C07K014/705
C07H021/04
US Classification:
435/069100, 530/350000, 435/320100, 435/325000, 536/023500
Abstract:
The invention provides human G-protein coupled receptors (GCREC) and polynucleotides which identify and encode GCREC. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with aberrant expression of GCREC.

Selection Probe Amplification

View page
US Patent:
20060183132, Aug 17, 2006
Filed:
Feb 14, 2005
Appl. No.:
11/058432
Inventors:
Glenn Fu - Dublin CA, US
Laura Stuve - San Jose CA, US
John Sheehan - Mountain View CA, US
Amy Ollmann - Redwood City CA, US
Naiping Shen - Saratoga CA, US
Andrew Sparks - Saratoga CA, US
Dennis Ballinger - Menlo Park CA, US
Assignee:
Perlegen Sciences, Inc. - Mountain View CA
International Classification:
C12Q 1/68
C12P 19/34
US Classification:
435006000, 435091200
Abstract:
Multiple unique selection probes are provided in a single medium. Each selection probe has a sequence that is complementary to a unique target sequence that may be present in a sample under consideration. For example, each selection probe may be complementary to a sequence that includes one of the SNPs used to genotype an organism. Single-stranded selection probes anneal or hybridize with sample sequences having the unique target sequences specified by the selection probe sequences. Sequences from the sample that do not anneal or hybridize with the selection probes are separated from the bound sequences by an appropriate technique. The bound sequences can then be freed to provide a mixture of isolated target sequences, which can be used as needed for the application at hand.

Hybridization Of Genomic Nucleic Acid Without Complexity Reduction

View page
US Patent:
20070003938, Jan 4, 2007
Filed:
Jun 30, 2005
Appl. No.:
11/173309
Inventors:
Glenn Fu - Dublin CA, US
Heng Tao - Mountain View CA, US
Assignee:
Perlegen Sciences, Inc. - Mountain View CA
International Classification:
C12Q 1/68
US Classification:
435006000
Abstract:
Disclosed are techniques for reliably detecting target sequences in a complex nucleic acid sample, typically in the range of about 400 MB or greater, without employing a complexity reduction technique. The method employs relatively high quantities of a hybridization competitor, e.g., multiple times the amount of nucleic acid sample present. When the sample and competitor come in contact with nucleic acid probes complementary to target sequences, for an appropriate length of time under defined hybridization conditions (buffer composition, temperature, etc.), the target and probe hybridize reliably.
Glenn K Fu from Dublin, CA, age ~54 Get Report